Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib	Non-squamous NSCLC	Recruiting	Phase 2	2024-12-04		NCT06206850

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jair Bar, M.D., Ph.D.	1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sheba Medical Center	Ramat Gan	Israel	1
Sheba Medical Center, Jusidman Cancer Center	Ramat Gan	Israel	1

Clinical trials